Today the U.S. Food and Drug Administration expanded the approved use of Yervoy (ipilimumab) to include a new use as adjuvant therapy for patients with stage III melanoma, to lower the risk that the melanoma will return following surgery.
Publications
New Melanoma Drug Uses Tumor-Busting Virus
The Food and Drug Administration approved a new drug Tuesday that uses a genetically engineered cold sore virus to bust up melanoma skin cancer tumors.
It’s the first drug of its type to get FDA approval. It’s made using a genetically engineered herpes virus — the same kind that causes cold sores — that carries an immune system compound into tumors, causing them to burst apart.
The drug, called Imlygic, doesn’t cure the patient and it has not been shown to help patients live longer, But it provides relief from melanoma, the deadliest form of skin cancer.
Scientific Journals for September & October2015
________________________________________________ DNA methylation subgroups in melanoma are associated with proliferative and immunological processes Martin Lauss1, Markus Ringnér1, Anna Karlsson1, Katja Harbst1, Christian Busch23,Jürgen Geisler234, Per Eystein Lønning235, Johan Staaf1 and Göran Jönsson1* BMC Medical Genomics 2015, 8:73 doi:10.1186/s12920-015-0147-4 Prickett et…
Read More Vitamin B3 can lower risk of skin cancer, researchers find
A simple oral dose of an active form of vitamin B3 may be the secret to stopping people with significant sun damage from developing some forms of skin cancer.
New research from the University of Sydney has found that a high dose of vitamin B derivative nicotinamide can prevent up to a quarter of non-melanoma skin cancers.